Olaparib, an inhibitor of poly(ADP-ribose) polymerase 1 (PARP), demonstrated proven senogenic effects on ovarian cancer cells [137]
With the current absence of technologies to rectify the actual mutations that underlie mitochondrial diseases, medical science can only address the resulting oxidative stress as a potential therapeutic option
Clean Ingredients Avoid supplements that contain synthetic fillers, artificial flavors, or excessive sugars
J Cell Physiol
Glycolytic activity, capacity, and reserve are greater in PBMCs from PD patients than in those from controls [116], and this feature is evident in PBMCs from patients affected by RBD, which is known to convert to PD or related synucleinopathies [117]
doi: 10.3389/fnut.2016.00031, 16